Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Price Behavior
Key Price Behavior Insights: ⢠Momentum fade ⢠Support test ⢠Resistance ceiling Support Level: $63.0-$63.9 Resistance Level: $66.0-$68.7 CNC rallied from the mid-$64s to about $68.72, then reversed into lower highs and closes, leaving price near $63.41 with $63.0-$63.9 support and $66.0-$68.7 resistance. ŕ´
Sentiment & News
Key News Insights: ⢠Margin improvement ⢠AI efficiency ⢠Contract renewal Centene's strong 2026 rally reflects improving earnings prospects from AI-driven efficiency, Medicaid margin discipline, and a key Illinois contract renewal, though Q2 results will test near-term execution.
AI Summary
Centene has shifted from a survival trade to a âprove the margin repair is durableâ story, but with the stock already rerated, the July 28 Q2 print is now the निरŕĽŕ¤Łining catalyst that will determine whether recent EPS beats, guidance raises, and the Meridian renewal translate into a sustainable earnings re-rating or fade under medical-cost and membership pressure.
Description
Centene Corporation is a multinational healthcare company that provides programs and services primarily for under-insured and uninsured individuals in the U.S., delivering government-funded managed care across Medicaid, CHIP, long-term services and supports, foster care, and plans for dually eligible and disabled populations, alongside commercial insurance products. Its offerings span clinical and non-clinical care coordination, pharmacy and behavioral health services, telehealth and home-based care, and supplemental services for vision, dental and transportation; a separate specialty-services unit provides pharmacy benefits management, nurse advice lines, correctional and military health support, and related staffing. The company was founded in 1984 and is headquartered in St. Louis, Missouri.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CNC | Centene Corporation | Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment. | Closed | +6.9% |